National Institutes of Health (NIH) — 2017 Investments
267 investments dated 2017 · page 1 of 2 · listed companies and verified rows first · show all
CEL-SCI is a biotechnology company developing cancer immunotherapy products, including its lead candidate Multikine for head and neck cancer, which showed a survival benefit in a Phase III trial.
BiotechHealthtechVienna, US
Peter Young(Director)Patricia B. Prichep(Executive Officer)Eyal Talor(Executive Officer)Geert R. Kersten(Executive Officer, Director)Bruno Baillavoine(Director)Daniel H. Zimmerman(Executive Officer)
BiotechPrinceton, US
Adam T. Rumage(Executive Officer)Richard C. Straube, MD MSc(Executive Officer)Karen Krumeich(Executive Officer)Oreola Donini, PhD(Executive Officer)Keith L. Brownlie, CPA(Director)Jerome B. Zeldis, PhD(Director)
HealthtechSt. Paul, US
Angeline Conley(Executive Officer, Director)Aaron Fletcher(Director)Donald Santel(Director)Steve Seme(Executive Officer)
Contract research organization specializing in CNS preclinical efficacy and neurotoxicity evaluations using its patented Enhanced Spine Profiling (ESP) technology.
AmideBio uses in-silico design and proprietary peptide synthesis to develop preclinical peptide drug candidates for metabolic disease.
BiotechDeep TechBoulder, US
David Barker(Director)Vincent P. Mihalik(Director)Michael H.B. Stowell(Executive Officer, Director)Ruel C. Mercure(Director)Mikhail Plam(Executive Officer, Director)Niles Utlaut(Director)
Bend, US
Jean-Paul Audette(Executive Officer, Director, Promoter)Adam S. Carroll(Executive Officer, Director, Promoter)Christopher Kraybill(Director)J. Corey Schmid(Director)
AyuVis is a biotechnology company developing small-molecule immunotherapies that modulate white blood cells to treat life-threatening inflammation and infection without causing immunosuppression or drug resistance.
BiotechHealthtechMedical DevicesFort Worth, US
Suchismita Acharya(Executive Officer, Director)Gagan Acharya(Executive Officer, Director)Stella M Robertson(Director)
Provides technologies for detection, neutralization, and removal of endotoxin for bioresearch and bioprocess markets.
BiVACOR is a clinical-stage medical device company developing a Total Artificial Heart (TAH), an electro-mechanical rotary blood pump with a single magnetically levitated rotor that replaces both ventricles for patients with end-stage biventricular heart failure.
HardwareHealthtechMedical DevicesHuntington Beach, US
Daniel Timms(Founder & Chief Technical Officer)James Dillon(Executive Officer, Director)William E. Cohn(Director)Tom Vassiliades(Executive Officer, Director)William Cohn(Chief Medical Officer)
BoardBihua Chen(Director)
HealthtechSt. Louis, US
Warren Watson(Director)William Schmidt(Director)Robert J. Calcaterra(Director)Brian Buetner(Director)M. Brent Shelton(Executive Officer)Paula Skjefte(Executive Officer, Director)
Click Diagnostics offers the Visby device, an at-home PCR test that delivers results in about 30 minutes for common curable STIs including chlamydia, gonorrhea, and trichomoniasis.
BiotechConsumerDigital HealthMedical DevicesMenlo Park, US
AJIT SINGH(Executive Officer, Director)JEROME BEHAR(Director)ADAM DE LA ZERDA(Director, Promoter)STEVEN ROSSTON(Director)
BiotechHealthtechBaltimore, US
Steven Tropello(Executive Officer, Director)Howard Carolan(Executive Officer, Director)William Niland(Director)Jeffrey Katz(Director)
BoardJohn Osborne(Director)Peter Boyd(Director)
Curtana Pharmaceuticals is a clinical-stage biotechnology company developing small-molecule inhibitors for brain cancer, particularly pediatric high-grade glioma.
BiotechMedical DevicesAustin, US
Eclipsebio provides RNA biology expertise and analytical technologies for drug developers and researchers, offering AI-powered sequence design, nucleotide-level characterization, and sequencing-based assays across small oligonucleotides, small molecules targeting RNA, AI training data, and basic research applications.
AI & Machine LearningBiotechDeep TechSan Diego, US
Eugene Yeo(Director)Peter Chu(Executive Officer, Director)Eric L Van Nostrand(Director)Hallie Kuhn(Director)
BoardEdmond Wong(Director)Daniel Vasella(Director)
EncepHeal develops small-molecule medications targeting the dopamine transporter to treat stimulant addiction, including cocaine and methamphetamine, for which no FDA-approved treatments currently exist.
BiotechHealthtechWinston-Salem, US
Aaron Lazarus(Founder)inOmeed Rahimi(Founder)in
FLAG Therapeutics is a clinical-stage drug developer creating small molecule therapeutics for difficult-to-treat cancers.
BiotechHealthtechRaleigh, US
FRANK L. SORGI(Executive Officer, Director)RUHI AHMED(Executive Officer)
HealthtechLong Island City, US
Mark Mathews(Director)Paul Gilbert(Executive Officer, Director)
Hemex Health develops and commercializes the Gazelle diagnostic platform, including point-of-care readers and tests for conditions such as sickle cell disease and hemoglobin variants.
Digital HealthHealthtechMedical DevicesPortland, US
Prakash Agarwal(Director)Mohan Uttarwar(Director)Patricia White Seminario(Executive Officer, Director, Promoter)Peter Galen(Chief Innovation Officer, Co-Founder)Susan Morgensztern(Director)Annette Mulee(Director, Promoter)
Hesperos develops "Human-on-a-Chip" organ-on-a-chip platforms, offering custom multi-organ models (up to 5 organ or tissue types) with functional readouts such as gene expression and electrophysiology.
BiotechDeep TechMedical DevicesOrlando, US
Michael Shuler(Co-founder)James Hickman(Co-founder)Michael L. Shuler(Co-founder)inJames J. Hickman(Co-founder & Chief Scientist)inLawrence Florin(Chief Executive Officer)James Stanker(CFO)
A biotechnology company developing a ground-breaking platform of therapeutics called GEM-DIMERs.
BiotechBurlingame, US
Harold E. Selick, PhD(Executive Officer, Director)Miriam Siekevitz(Executive Officer)Daniel J. Capon(Director)Malcolm L. Gefter(Director)William D. Unger(Director)Samuel Saks(Director)
Inhibrx Biosciences, Inc. is a biotechnology company that was spun off as a subsidiary of Inhibrx, Inc. through a pro rata distribution of shares to shareholders.
BiotechLa Jolla, US
Mark Lappe(Executive Officer, Director)Doug Forsyth(Director)Brendan Eckelman(Director)Jon Faiz Kayyem(Director)Margery Fischbein(Director)
BoardJudith Li(Director)
iotaMotion develops robotic systems for cochlear implant surgery, assisting otolaryngologists in achieving precision beyond human capability.
HealthtechMedical DevicesRoboticsSt. Paul, US
Marlan Hansen, MD(Executive Officer, Director)Michael Lobinsky(Executive Officer, Director)Marlan Hansen(Executive Officer, Director)Christopher Kaufmann(Executive Officer, Director)
BoardWayne Wallace(Director)Michael Crook(Director)
LightDeck Diagnostics, a diagnostics company, is now part of Antech Diagnostics.
Digital HealthMedical Devices
MicroMGx operates a metabologenomics platform that combines metabolomics, genomics, bioinformatics, and AI to discover novel natural products from microbial strain collections.
AgTechAI & Machine LearningBiotechEvanston, US
Regan Thomson(Director and Co-Founder)Jennifer Kelleher(COO and Corporate Secretary)William Metcalf(Chairman of the Board and CoFounder)Neil Kelleher(Director and CoFounder)Jack Kloeber(CEO and Co-Founder)Anthony Goering(Director)
Oligomerix is a clinical-stage biotechnology company developing oral, disease-modifying small molecule inhibitors that target tau protein self-association and aggregation.
BiotechDeep TechLongevity
Ossium Health develops cellular therapies and bioengineered products for clinical use, leveraging adult stem cell technologies and advanced cell processing platforms.
BiotechHealthtechMedical DevicesSan Francisco, US
Kevin Caldwell(CEO, Co-Founder & President)Dr. Woods(Chief Science Officer, Co-Founder, EVP, CLIA Laboratory Director)William Trenchard(Director)Sebastian Giwa(Director)Thomas Cycyota(Director)
PECA Labs develops cardiovascular implants—including vascular grafts and the MASA Valve, a polymeric bi-leaflet valved conduit for pulmonary valve reconstruction—based on a proprietary tunable polymeric material platform.
BiotechHealthtechMedical DevicesNew MaterialsPittsburgh, US
C. Douglas Bernstein(CEO)Rajan Kalra(Director)David Smith(Executive Officer)
BoardSamuel Navarro(Director)Michael Moriarty(Director)Dr. Jeffrey Carpenter(Director)
Pharmazz is a biopharmaceutical company developing and commercializing therapeutics for critical care and acute medicine, focused on Endothelin-B receptor agonists and resuscitative agents for conditions such as hypovolemic shock, ischemic stroke, and septic shock.
BiotechHealthtechWillowbrook, US
Anil Gulati(Founder & CEO)David Costello(Executive Officer)Sunil Gulati(Executive Officer)Daniel Stauder(Executive Officer)Ajit Srimal(Director)Gaylord Toft(Executive Vice President)
HealthtechDurham, US
ERIC T. ESPENHAHN(Executive Officer)CHRIS DUNN(Director)CHARLES A. PELL(Executive Officer, Director)HUGH C. CRENSHAW(Executive Officer, Director)KEVIN SCHIMELFENIG(Director)R. FREDERICK MCCOY, JR.(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.